21-hydroxylase deficiency classification: Difference between revisions
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency may be classified into several subtypes based on severity, time of onset (mild, moderate, and severe), and the presence of [[virilization]] (stage I to stage V). | Congenital adrenal hyperplasia due to 21-hydroxylase deficiency may be classified into several subtypes based on severity, time of onset (mild, moderate, and severe), and the presence of [[virilization]] (stage I to stage V). | ||
{{CMG}}; '''Associate Editor-In-Chief:''' {{MJ}} | |||
==Overview== | |||
==Classification== | ==Classification== | ||
Congenital adrenal hyperplasia may be classified in to seven different types, based on specified genetic mutation as following:<ref name="pmid28576284">{{cite journal |vauthors=El-Maouche D, Arlt W, Merke DP |title=Congenital adrenal hyperplasia |journal=Lancet |volume= |issue= |pages= |year=2017 |pmid=28576284 |doi=10.1016/S0140-6736(17)31431-9 |url=}}</ref> | |||
* 21-hydroxylase deficiency | |||
** Genetic defects: CYP21A2 | |||
** The most common cause of congenital adrenal hyperplasia worldwide, accounting for more than 95 percent of cases, is 21-hydroxylase deficiency** 21-OHD is classified into 3 subtypes according to clinical severity: | |||
*** classic salt wasting (SW) | |||
*** classic simple virilizing (SV) | |||
*** Nonclassic CAH (NCCAH; mild or late onset)<ref name="pmid28476231">{{cite journal |vauthors=Hannah-Shmouni F, Chen W, Merke DP |title=Genetics of Congenital Adrenal Hyperplasia |journal=Endocrinol. Metab. Clin. North Am. |volume=46 |issue=2 |pages=435–458 |year=2017 |pmid=28476231 |doi=10.1016/j.ecl.2017.01.008 |url=}}</ref> | |||
* 11β-hydroxylase deficiency | |||
** Genetic defect: CYP11B1 | |||
* 17α-hydroxylase/ 17,20-lyase deficiency | |||
** Genetic defect: CYP17A1 | |||
* 3β-hydroxy-steroid dehydrogenase type 2 deficiency | |||
** Genetic defect: HSD3B2 | |||
* P450 oxidoreductase deficiency | |||
** Genetic defect: POR | |||
* Lipoid adrenal hyperplasia | |||
** Genetic defect: StAR | |||
* Cholesterol side chain cleavage enzyme deficiency | |||
** Genetic defect: CYP11A1 | |||
== | ==References== | ||
{{Reflist|2}} | |||
[[Category:Disease]] | |||
[[Category:Pediatrics]] | |||
[[Category:Endocrinology]] | |||
[[Category:Genetic disorders]] | |||
[[Category:Intersexuality]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
==References== | ==References== |
Revision as of 13:49, 12 July 2017
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Microchapters |
Differentiating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
21-hydroxylase deficiency classification On the Web |
American Roentgen Ray Society Images of 21-hydroxylase deficiency classification |
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
Risk calculators and risk factors for 21-hydroxylase deficiency classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2] Ahmad Al Maradni, M.D. [3]
Overview
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency may be classified into several subtypes based on severity, time of onset (mild, moderate, and severe), and the presence of virilization (stage I to stage V).
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [4]; Associate Editor-In-Chief: Mehrian Jafarizade, M.D [5]
Overview
Classification
Congenital adrenal hyperplasia may be classified in to seven different types, based on specified genetic mutation as following:[1]
- 21-hydroxylase deficiency
- Genetic defects: CYP21A2
- The most common cause of congenital adrenal hyperplasia worldwide, accounting for more than 95 percent of cases, is 21-hydroxylase deficiency** 21-OHD is classified into 3 subtypes according to clinical severity:
- classic salt wasting (SW)
- classic simple virilizing (SV)
- Nonclassic CAH (NCCAH; mild or late onset)[2]
- 11β-hydroxylase deficiency
- Genetic defect: CYP11B1
- 17α-hydroxylase/ 17,20-lyase deficiency
- Genetic defect: CYP17A1
- 3β-hydroxy-steroid dehydrogenase type 2 deficiency
- Genetic defect: HSD3B2
- P450 oxidoreductase deficiency
- Genetic defect: POR
- Lipoid adrenal hyperplasia
- Genetic defect: StAR
- Cholesterol side chain cleavage enzyme deficiency
- Genetic defect: CYP11A1
References
- ↑ El-Maouche D, Arlt W, Merke DP (2017). "Congenital adrenal hyperplasia". Lancet. doi:10.1016/S0140-6736(17)31431-9. PMID 28576284.
- ↑ Hannah-Shmouni F, Chen W, Merke DP (2017). "Genetics of Congenital Adrenal Hyperplasia". Endocrinol. Metab. Clin. North Am. 46 (2): 435–458. doi:10.1016/j.ecl.2017.01.008. PMID 28476231.